166 related articles for article (PubMed ID: 36289662)
21. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
22. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.
Mucha O; Podkalicka P; Kaziród K; Samborowska E; Dulak J; Łoboda A
Skelet Muscle; 2021 Sep; 11(1):21. PubMed ID: 34479633
[TBL] [Abstract][Full Text] [Related]
24. Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.
Betts CA; Saleh AF; Carr CA; Hammond SM; Coenen-Stass AM; Godfrey C; McClorey G; Varela MA; Roberts TC; Clarke K; Gait MJ; Wood MJ
Sci Rep; 2015 Mar; 5():8986. PubMed ID: 25758104
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD Cardiomyopathy.
Morroni J; Schirone L; Valenti V; Zwergel C; Riera CS; Valente S; Vecchio D; Schiavon S; Ragno R; Mai A; Sciarretta S; Lozanoska-Ochser B; Bouchè M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216371
[TBL] [Abstract][Full Text] [Related]
26. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy.
Brogi L; Marchese M; Cellerino A; Licitra R; Naef V; Mero S; Bibbiani C; Fronte B
Nutrients; 2021 May; 13(5):. PubMed ID: 34065946
[TBL] [Abstract][Full Text] [Related]
27. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
[TBL] [Abstract][Full Text] [Related]
28. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
[TBL] [Abstract][Full Text] [Related]
29. Altered muscle niche contributes to myogenic deficit in the D2-
Mázala DAG; Hindupur R; Moon YJ; Shaikh F; Gamu IH; Alladi D; Panci G; Weiss-Gayet M; Chazaud B; Partridge TA; Novak JS; Jaiswal JK
bioRxiv; 2023 Mar; ():. PubMed ID: 37034785
[TBL] [Abstract][Full Text] [Related]
30. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
[TBL] [Abstract][Full Text] [Related]
31. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
[TBL] [Abstract][Full Text] [Related]
32. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
Alves FM; Kysenius K; Caldow MK; Hardee JP; Chung JD; Trieu J; Hare DJ; Crouch PJ; Ayton S; Bush AI; Lynch GS; Koopman R
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1541-1553. PubMed ID: 35249268
[TBL] [Abstract][Full Text] [Related]
33. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
34. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
[TBL] [Abstract][Full Text] [Related]
35. Label-free 3D characterization of cardiac fibrosis in muscular dystrophy using SHG imaging of cleared tissue.
Pichon J; Ledevin M; Larcher T; Jamme F; Rouger K; Dubreil L
Biol Cell; 2022 Mar; 114(3):91-103. PubMed ID: 34964145
[TBL] [Abstract][Full Text] [Related]
36. Second-generation compound for the modulation of utrophin in the therapy of DMD.
Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
[TBL] [Abstract][Full Text] [Related]
37. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.
Verma M; Shimizu-Motohashi Y; Asakura Y; Ennen JP; Bosco J; Zhou Z; Fong GH; Josiah S; Keefe D; Asakura A
PLoS Genet; 2019 Dec; 15(12):e1008468. PubMed ID: 31877123
[TBL] [Abstract][Full Text] [Related]
39. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
[TBL] [Abstract][Full Text] [Related]
40. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T
Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
